TP53 and head and neck squamous cell carcinoma: Unfortunately, the sample size is small in this study, for example, there were only nine HPV-positive patients and three HPV-negative patients being TP53 wildtype, which precluded the possibility for us to explore the potential correlation of TP53/TERT alternation, immune infiltrating cells, and HPV status in HNSCC.